Mary Elizabeth(beth) Klein
About Mary Elizabeth(beth) Klein
Mary Elizabeth (Beth) Klein serves as the President of IBA Proton Therapy North America, where she focuses on innovation and operational efficiency in proton therapy solutions. She has extensive experience in sales and management within the healthcare sector, having held leadership roles at IBA, TomoTherapy, and General Electric Healthcare.
Current Role at IBA Proton Therapy North America
Mary Elizabeth Klein serves as the President of IBA Proton Therapy North America, a position she has held since 2016. In this role, she has focused on enhancing operational efficiency and improving service delivery within the organization. Klein has been instrumental in expanding IBA's market presence in North America through strategic partnerships and collaborations. Her leadership has contributed to the advancement of proton therapy solutions in the healthcare sector.
Previous Experience at IBA
Prior to her current role, Klein worked at IBA as the Global Sales Director from 2009 to 2013. She also held the position of Executive Vice President of PT Sales North America from 2013 to 2015. During her tenure, she focused on sales strategies and market development, contributing to the company's growth in the proton therapy sector.
Career Background in Healthcare Sales
Klein has extensive experience in the healthcare industry. She served as the Executive Vice President of Global Sales at TomoTherapy from 2006 to 2008. Additionally, she worked at General Electric Healthcare as the Global General Manager for Nuclear Medicine and PET/CT from 1998 to 2001. Her roles have consistently involved leadership in sales and operational management in healthcare technology.
Educational Background
Klein earned a Bachelor of Science in Biology and a Bachelor of Arts in Languages from the University of Notre Dame, where she studied from 1974 to 1979. She later pursued a Master of Business Administration (MBA) at Northeastern University - Graduate School of Business Administration, completing her studies from 1987 to 1989. Her educational background supports her expertise in both the scientific and business aspects of healthcare.
Focus on Innovation and Technology Integration
Klein has a strong focus on innovation and technology integration within the healthcare sector, particularly in proton therapy solutions. Her efforts have been directed towards enhancing the capabilities and efficiency of proton therapy, reflecting her commitment to advancing treatment options in cancer care.